FGFR1 and breast cancer: The chr8:ZNF703/FGFR1 and chr11:CCND1 amplifications are amongst the most frequent in breast cancer, particularly in ER-positive breast tumours (19% and 28%, respectively, of amplifications in ER-positive tumours; 11% and 16%, respectively, of total cohort).